TRPV2 — Transient Receptor Potential Cation Channel Subfamily V Member 2

TRPV2 — Transient Receptor Potential Cation Channel Subfamily V Member 2

Overview

TRPV2 (Transient Receptor Potential Cation Channel Subfamily V Member 2), also known as VRL-1 (Vanilloid Receptor-like 1), is a non-selective calcium channel belonging to the TRP (Transient Receptor Potential) superfamily of ion channels. Originally identified as a thermosensitive channel activated by noxious heat (>52°C), TRPV2 has emerged as a multifunctional channel with critical roles in neuronal survival, calcium homeostasis, and neurodegenerative disease pathogenesis.

TRPV2 is widely expressed in the central and peripheral nervous systems, where it participates in various physiological and pathological processes. Research has implicated TRPV2 in the pathogenesis of several neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and stroke[@nagasawa2007][@sun2020][@zhang2019]. The channel's role in calcium dysregulation, excitotoxicity, and neuroinflammation positions it as both a potential therapeutic target and a biomarker for neurodegeneration.

TRPV2 — Transient Receptor Potential Cation Channel Subfamily V Member 2

Overview

TRPV2 (Transient Receptor Potential Cation Channel Subfamily V Member 2), also known as VRL-1 (Vanilloid Receptor-like 1), is a non-selective calcium channel belonging to the TRP (Transient Receptor Potential) superfamily of ion channels. Originally identified as a thermosensitive channel activated by noxious heat (>52°C), TRPV2 has emerged as a multifunctional channel with critical roles in neuronal survival, calcium homeostasis, and neurodegenerative disease pathogenesis.

TRPV2 is widely expressed in the central and peripheral nervous systems, where it participates in various physiological and pathological processes. Research has implicated TRPV2 in the pathogenesis of several neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and stroke[@nagasawa2007][@sun2020][@zhang2019]. The channel's role in calcium dysregulation, excitotoxicity, and neuroinflammation positions it as both a potential therapeutic target and a biomarker for neurodegeneration.

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">TRPV2 — Transient Receptor Potential Cation Channel Subfamily V Member 2</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>TRPV2</td></tr>
<tr><td><strong>Protein Name</strong></td><td>VRL-1, Transient receptor potential cation channel subfamily V member 2</td></tr>
<tr><td><strong>Chromosome</strong></td><td>17p11.2</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[12404](https://www.ncbi.nlm.nih.gov/gene/12404)</td></tr>
<tr><td><strong>OMIM</strong></td><td>607949</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000173372</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9Y5S2](https://www.uniprot.org/uniprot/Q9Y5S2)</td></tr>
<tr><td><strong>Protein Family</strong></td><td>TRPV (Vanilloid-like) family</td></tr>
<tr><td><strong>Subcellular Location</strong></td><td>Plasma membrane, endosomes</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>AD, PD, ALS, Stroke, Pain disorders</td></tr>
</table>
</div>

Gene and Protein Structure

Genomic Organization

The TRPV2 gene is located on chromosome 17p11.2 and spans approximately 39 kb of genomic DNA. The gene consists of 18 exons that encode a protein of 761 amino acids with a molecular weight of approximately 84 kDa. The gene promoter contains multiple regulatory elements including AP-1, NF-κB, and CREB binding sites, allowing for complex transcriptional regulation in response to various cellular signals and pathological conditions[@boeda2019].

Protein Domain Architecture

TRPV2 shares structural homology with other TRPV family members and contains several distinctive domains:

Channel Properties

TRPV2 exhibits distinct biophysical properties:

• Ion selectivity: Non-selective calcium-permeable channel (PCa/PNa ~10)
• Activation: Noxious heat (>52°C), mechanical stimuli, endogenous ligands
• Pharmacology: Insensitive to capsaicin (unlike TRPV1)
• Desensitization: Minimal desensitization compared to TRPV1

Expression in the Nervous System

Brain Regional Distribution

TRPV2 is highly expressed in multiple brain regions[@nagasawa2007]:

| Brain Region | Expression Level | Cell Types |
|-------------|-----------------|------------|
| [Cerebral Cortex](/brain-regions/cortex) | High | Layer 5 pyramidal neurons |
| [Hippocampus](/brain-regions/hippocampus) | High | CA1-CA3 pyramidal neurons, dentate gyrus |
| [Basal Ganglia](/brain-regions/striatum) | High | Striatal neurons, substantia nigra pars compacta |
| [Thalamus](/brain-regions/thalamus) | Moderate | Relay neurons |
| [Cerebellum](/brain-regions/cerebellum) | Moderate | Purkinje cells |
| Spinal Cord | High | Dorsal horn neurons, motor neurons |

Cell Type Expression

• Excitatory neurons: High expression throughout cortex and hippocampus
• Inhibitory neurons: Moderate expression in interneurons
• [Astrocytes](/entities/astrocytes): Inducible expression under pathological conditions
• [Microglia](/cell-types/microglia-neuroinflammation): Activated in neuroinflammation
• Oligodendrocytes: Low baseline, increased in demyelination

Subcellular Localization

TRPV2 exhibits dynamic subcellular distribution:

• Plasma membrane: Primary location for ion channel function
• Endoplasmic reticulum: Calcium release and signaling
• Endosomes: Intracellular calcium handling
• Lysosomes: Autophagy regulation
• Mitochondria: Calcium buffering and metabolic regulation

Normal Physiological Functions

Calcium Homeostasis

TRPV2 functions as a calcium-permeable channel that contributes to intracellular calcium signaling:

Unlike TRPV1, which is activated by capsaicin and noxious heat (>43°C), TRPV2 is considered a thermosensitive channel primarily activated by noxious heat (>52°C) and mechanical stimuli[@caterina2000].

Neuronal Survival and Death

In healthy neurons, TRPV2 plays a dual role in cell fate decisions[@jara2017]:

Neuroprotective signaling:

• Moderate activation triggers pro-survival pathways
• Activation of calcium-dependent transcription factors
• Induction of antioxidant defenses
• Promotion of autophagy

• Excessive calcium influx leads to cell death
• Mitochondrial calcium overload
• Activation of calcium-dependent proteases
• Oxidative stress

• Channel activity levels
• Cellular context
• Co-activation of other signaling pathways
• Cellular energy status

Glial Function

TRPV2 is expressed in glial cells where it participates in[@liu2022]:

• Astrocyte calcium signaling: Modulates astrocyte-neuron communication
• Microglial activation: Influences inflammatory responses
• Oligodendrocyte function: Affects myelination processes
• Glial scar formation: Involved in injury responses

Mechanosensation

TRPV2 functions as a mechanosensitive channel:

• Neuronal mechanotransduction: Responds to membrane stretch
• Proprioception: Contributes to sensing mechanical forces
• Touch sensation: Participates in peripheral sensory processing
• Blood pressure regulation: Baroreceptor function

Role in Neurodegenerative Diseases

Alzheimer's Disease

In Alzheimer's disease, TRPV2 expression and function are altered in brain regions affected by neurodegeneration[@sun2020][@suh2023]:

Expression changes:

• Increased TRPV2 expression in early AD hippocampus and cortex
• Altered subcellular localization in affected neurons
• Dysregulated channel trafficking

Therapeutic implications:

• TRPV2 antagonists may reduce calcium-mediated excitotoxicity
• Modulators could restore normal calcium homeostasis
• Targeting TRPV2 may protect against Abeta toxicity

Parkinson's Disease

TRPV2 may play a role in PD pathogenesis through multiple mechanisms[@zhang2019]:

Dopaminergic neuron vulnerability:

• TRPV2 expression in substantia nigra pars compacta neurons
• Age-related changes in TRPV2 function
• Enhanced vulnerability to oxidative stress

Therapeutic potential:

• Neuroprotective strategies targeting TRPV2
• Modulation of calcium homeostasis
• Combination with other disease-modifying approaches

Amyotrophic Lateral Sclerosis

In ALS, TRPV2 is implicated in multiple pathogenic processes[@cheng2021]:

Disease mechanisms:

• Dysregulated calcium handling in motor neurons
• Enhanced sensitivity to excitotoxic stimuli
• Accelerated disease progression

Stroke and Brain Injury

Following cerebral ischemia, TRPV2 plays complex roles[@park2020]:

Early phase (neuroprotective):

• Moderate activation promotes survival signaling
• Activation of calcium-dependent protective pathways
• Induction of adaptive stress responses

• Exacerbates excitotoxic cell death
• Contributes to inflammatory damage
• Promotes blood-brain barrier disruption

Aging and Neurodegeneration

TRPV2 function changes with aging[@zhou2022]:

• Altered channel expression and localization
• Enhanced susceptibility to pathological stimuli
• Dysregulated calcium homeostasis
• Impaired neuroprotective signaling

Interaction Network

Protein-Protein Interactions

TRPV2 interacts with multiple cellular proteins:

Channel regulators:

• PI3K: Modulates channel trafficking
• PKC: Regulates channel activity
• Calmodulin: Calcium-dependent regulation
• Caveolin: Membrane microdomain organization

• IP3 receptor: Calcium release
• Mitochondrial calcium carriers
• Autophagy machinery
• Cytoskeletal proteins

Signaling Pathway Integration

TRPV2 integrates with multiple signaling pathways:

• Calcium signaling: Calmodulin, CaMK, calcineurin
• PI3K/Akt pathway: Cell survival signaling
• MAPK pathway: Stress responses
• NF-κB pathway: Inflammatory responses
• Autophagy pathway: Cellular quality control

Therapeutic Implications

Drug Development

TRPV2 represents a potential therapeutic target for neurodegenerative diseases[@wang2021]:

| Strategy | Approach | Development Status |
|----------|----------|-------------------|
| Antagonists | Reduce calcium influx | Preclinical |
| Modulators | Restore homeostasis | Research |
| Positive allosteric | Enhance neuroprotection | Early research |
| Gene therapy | Modulate expression | Preclinical |

Challenges

Research Directions

• Develop selective TRPV2 modulators
• Understand tissue-specific channel functions
• Identify disease-specific activation mechanisms
• Validate therapeutic targets in models

Animal Models

Genetic Models

| Model | Modification | Phenotype |
|-------|-------------|-----------|
| TRPV2 knockout | Deletion | Viable, sensory deficits |
| TRPV2 transgenic | Overexpression | Enhanced pain, altered behavior |
| Conditional KO | Cell-type specific | Context-dependent effects |

Disease Models

• APP/TRPV2: Interaction with amyloid pathology
• α-syn/TRPV2: Modulation of synuclein toxicity
• ALS model/TRPV2: Motor neuron vulnerability
• Ischemia/TRPV2: Stroke outcomes

Biomarker Potential

TRPV2 as Disease Biomarker

• Expression changes: Detectible in peripheral tissues
• Genetic variants: Associated with disease risk
• Therapeutic monitoring: Tracks treatment response

Research Directions

• Develop detection methods for clinical use
• Validate in patient cohorts
• Establish disease-specific signatures

Cross-Links

TRPV2 connects to multiple NeuroWiki pages:

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis)
• [Calcium Dysregulation](/mechanisms/calcium-dysregulation)
• [Excitotoxicity](/mechanisms/excitotoxicity)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [TRPV1](/genes/trpv1)
• [TRPV3](/genes/trpv3)
• [TRPV4](/genes/trpv4)
• [Stroke](/diseases/stroke)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving TRPV2 — Transient Receptor Potential Cation Channel Subfamily V Member 2 discovered through SciDEX knowledge graph analysis: